PITTSBURGH, June 25, 2025 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (OTC: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on developing therapies for diseases with significant unmet need, today issued a letter from Chief Executive Officer Jonathan Kaufman to stockholders. The letter provides detailed responses to frequently asked questions regarding the Company's recent delisting from the Nasdaq Capital Market, as well as insight into Lipella's clinical programs, financial position, and plans to relist on a national exchange.

Grants advance research and pilot programs to prevent musculoskeletal disorders WASHINGTON , June 25, 2025 /PRNewswire/ -- The National Safety Council awarded $300,000 to the 2025-2026 Research to Solutions (R2S) and MSD Solutions Pilot Grant recipients, bringing the total investment in musculoskeletal disorders (MSDs) prevention to nearly $850,000 over three years. The grants support academic research and workplace pilot programs through the NSC MSD Solutions Lab, established in 2021 with funding from Amazon (NASDAQ: AMZN).

Dream Finders Homes operates in key regions, where 77% of total immigration to the U.S. arrives. The company has a solid growth outlook compared to its historical average and its competition. Even at a conservative valuation, its share price gives me a 40% potential upside.

EZA has outperformed gold, global banks, and the S&P 500 since October 2023, driven by strong momentum and a bullish macro backdrop. The ETF offers a compelling valuation, with a P/E just above 10 and a PEG ratio under 1.0x, plus a high 5.81% dividend yield. EZA's portfolio is concentrated in Financials and Materials, making it sensitive to trends in global banking and gold prices.

SAN FRANCISCO--(BUSINESS WIRE)-- #cre--Cushman & Wakefield announced today that JP LeVeque has joined the firm as Executive Vice Chair.

San Antonio, TX, June 25, 2025 (GLOBE NEWSWIRE) -- U.S. Global Investors, Inc. (NASDAQ: GROW), a registered investment advisory firm[1] with expertise in gold mining stocks and the airline industry, is pleased to announce that it will continue its payment of monthly dividends.

"No one would've guessed" markets would be where they are now, says Robert Schein when looking back to April's lows. He points to an expected interest rate cut from the Fed and tax cuts from Congress as bullish signals to watch for.

NEW YORK , June 25, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of West Pharmaceutical Services, Inc. (NYSE: WST) between February 16, 2023 and February 12, 2025, both dates inclusive (the "Class Period"), of the important July 7, 2025 lead plaintiff deadline. So what: If you purchased West Pharmaceutical common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Nebius Group remains a buy for me, as the fundamental AI infrastructure thesis is intact despite recent volatility and high beta. Technical analysis suggests more upside potential, with bullish moving average crossovers and a possible inverse head and shoulders pattern forming. The current consolidation phase may present a good entry point, but prudent position sizing is crucial given NBIS's volatility.

NEW YORK, June 25, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of SelectQuote, Inc. (NYSE: SLQT) resulting from allegations that SelectQuote may have issued materially misleading business information to the investing public.

Southwest CEO Bob Jordan said the company is open to making even more changes to woo customers who might be flying on competitors. Airport lounges, long-haul international flights and more premium class are all on the table, Jordan told CNBC.

Applied Materials is well positioned to benefit from AI-driven semiconductor megatrends, with WFE market growth expected to accelerate due to larger, more complex chips. Sticky, recurring revenues from Applied Global Services reduce cyclicality and provide stable cash flows, supporting a more predictable business model. Strong capital return policy, including growing dividends and share buybacks, underscores management's confidence and shareholder alignment.

NEW YORK , June 25, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Sable Offshore Corp. (NYSE: SOC), including those who purchased shares pursuant to Sable Offshore Corp.'s May 2025 public offering, resulting from allegations that Sable Offshore Corp. may have issued materially misleading business information to the investing public. So What: If you purchased Sable Offshore Corp. securities, including pursuant to Sable Offshore Corp.'s May 2025 public offering, you may be entitled to compensation without payment of any out of pocket fees …

NEW YORK, June 25, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of DoubleVerify Holdings, Inc. (NYSE: DV) between November 10, 2023 and February 27, 2025, both dates inclusive (the “Class Period”), of the important July 21, 2025 lead plaintiff deadline.

Next week brings the start of July, and with it another holiday.

NEW YORK, June 25, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Fortrea Holdings, Inc. (NASDAQ: FTRE) between July 3, 2023 and February 28, 2025, both dates inclusive (the “Class Period”), of the important August 1, 2025 lead plaintiff deadline.

NEW YORK, June 25, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Elevance Health, Inc. (NYSE: ELV) between April 18, 2024 and October 16, 2024, both dates inclusive (the “Class Period”), of the important July 11, 2025 lead plaintiff deadline.

The market is overestimating the negative impact of policy crackdowns, DoJ investigations, and Medicare/Medicaid cuts on UnitedHealth Group's long-term fundamentals. While legislative and regulatory headwinds will likely compress margins and slow growth, UNH's diversified business model and strong market position provide resilience and upside potential. Optum Insights is a key growth catalyst, with double-digit margin expansion and AI-driven healthcare analytics offsetting weakness in other segments.

Paul Sankey, Sankey Research, joins 'Power Lunch' to discuss Sankey's take on reports of Shell's potential acquisition of BP.

As AT&T transitions its broadband service from copper to fiber, the company anticipates $6 billion in cost savings when its copper network is taken off-line. CFO Pascal Desroches says the company is also getting financial returns from selling the copper it's no longer using.